These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 17852450)
1. Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model. Mihou D; Katodritou E; Zervas K Hematology; 2007 Dec; 12(6):527-31. PubMed ID: 17852450 [TBL] [Abstract][Full Text] [Related]
2. [Assessment of Heavy/ Light Chain Pairs of Immunoglobulin (Hevylite assay) - Benefit for Stratification of Multiple Myeloma?]. Ščudla V; Lochaman P; Pika T; Zapletalová J; Minařík J; Bačovský J Klin Onkol; 2015; 28(5):359-69. PubMed ID: 26480864 [TBL] [Abstract][Full Text] [Related]
3. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy. Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients]. Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972 [TBL] [Abstract][Full Text] [Related]
5. International staging system for multiple myeloma. Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system]. Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648 [TBL] [Abstract][Full Text] [Related]
7. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels. Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases]. Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681 [TBL] [Abstract][Full Text] [Related]
9. Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma. Jakob C; Sterz J; Liebisch P; Mieth M; Rademacher J; Goerke A; Heider U; Fleissner C; Kaiser M; von Metzler I; Müller C; Sezer O Leukemia; 2008 Sep; 22(9):1767-72. PubMed ID: 18580957 [TBL] [Abstract][Full Text] [Related]
10. The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia. Dimopoulos M; Gika D; Zervas K; Kyrtsonis M; Symeonidis A; Anagnostopoulos A; Bourantas K; Matsouka C; Pangalis G Leuk Lymphoma; 2004 Sep; 45(9):1809-13. PubMed ID: 15223640 [TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors. Anagnostopoulos A; Gika D; Hamilos G; Zervas K; Zomas A; Pouli A; Zorzou M; Kastritis E; Anagnostopoulos N; Tassidou A; Anagnostou D; Dimopoulos MA Leuk Lymphoma; 2004 Nov; 45(11):2275-9. PubMed ID: 15512817 [TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma. Hsiao LT; Yang CF; Yang SH; Gau JP; Yu YB; Hong YC; Liu CY; Liu JH; Chen PM; Chiou TJ; Tzeng CH Eur J Haematol; 2012 Feb; 88(2):159-66. PubMed ID: 21973045 [TBL] [Abstract][Full Text] [Related]
13. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I. Gastinne T; Leleu X; Duhamel A; Moreau AS; Franck G; Andrieux J; Lai JL; Coiteux V; Yakoub-Agha I; Bauters F; Harousseau JL; Zandecki M; Facon T; Eur J Haematol; 2007 Oct; 79(4):297-304. PubMed ID: 17692103 [TBL] [Abstract][Full Text] [Related]
14. [Classification, staging and prognostic indices for multiple myeloma]. Hotta T Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256 [TBL] [Abstract][Full Text] [Related]
15. A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience. Jacobson JL; Hussein MA; Barlogie B; Durie BG; Crowley JJ; Br J Haematol; 2003 Aug; 122(3):441-50. PubMed ID: 12877671 [TBL] [Abstract][Full Text] [Related]
16. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System]. Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604 [TBL] [Abstract][Full Text] [Related]
17. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count. Perosa F; Minoia C; Favoino E; Prete M; Dammacco F Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and staging systems of multiple myeloma: Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664 [TBL] [Abstract][Full Text] [Related]